Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia

Published:2020-07-23 Issue:6 Volume:190 Page:933-938
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Boccia Ralph¹,Cooper Nichola²,Ghanima Waleed³⁴,Boxer Michael A⁵,Hill Quentin A.⁶^ORCID,Sholzberg Michelle⁷^ORCID,Tarantino Michael D.⁸,Todd Leslie K.⁹^ORCID,Tong Sandra⁹,Bussel James B.¹⁰^ORCID,

Affiliation:

1. Centre for Cancer and Blood Disorders Bethesda MD USA

2. Imperial College Healthcare NHS TrustHammersmith Hospital London UK

3. Department of Research Østfold Hospital Trust Sarpsborg Norway

4. Department of Hematology Institute of Clinical Medicine, University of Oslo Oslo Norway

5. Arizona Oncology Associates Tucson AZ USA

6. Department of Haematology St. James University Hospital Leeds UK

7. St. Michael's Hospital Toronto ON Canada

8. The Bleeding and Clotting Disorders Institute University of Illinois College of Medicine‐Peoria Peoria IL USA

9. Rigel Pharmaceuticals, Inc South San Francisco CA USA

10. Department of Pediatrics Weill Cornell Medicine New York NY USA

Funder

Rigel Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16959

Reference22 articles.

1. American Society of Hematology 2019 guidelines for immune thrombocytopenia

2. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

3. The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper

4. Treatment of acute immune thrombocytopenic purpura;Tarantino MD;Semin Hematol,1998

5. Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment;Blood Reviews;2024-09

2. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice;Blood;2024-08-08

3. Sovleplenib in immune thrombocytopenia;The Lancet Haematology;2024-08

4. Diagnosis and management of Evans syndrome in adults: first consensus recommendations;The Lancet Haematology;2024-08

5. Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience;Blood Coagulation & Fibrinolysis;2024-07-16